Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Onyx reports positive results from carfilzomib Phase 2b 003-A1 study in multiple myeloma

Onyx reports positive results from carfilzomib Phase 2b 003-A1 study in multiple myeloma

Experimental treatment for sickle cell disease enters Phase 3 clinical trials

Experimental treatment for sickle cell disease enters Phase 3 clinical trials

Babesiosis disease on the rise in Lower Hudson Valley: NYS DOH

Babesiosis disease on the rise in Lower Hudson Valley: NYS DOH

Taiho Pharmaceutical receives approval to market ABRAXANE IV Infusion 100 mg in Japan

Taiho Pharmaceutical receives approval to market ABRAXANE IV Infusion 100 mg in Japan

Pneumonia, diarrhea, and malaria cause death of 6 million of world's poorest children

Pneumonia, diarrhea, and malaria cause death of 6 million of world's poorest children

Discontinuing epoetin can normalize hemoglobin levels in hemodialysis patients

Discontinuing epoetin can normalize hemoglobin levels in hemodialysis patients

ASH to honor six scientists for treatment of hematologic diseases

ASH to honor six scientists for treatment of hematologic diseases

Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia

Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia

Drugs can save African infants' lives

Drugs can save African infants' lives

La Jolla Institute forms partnership to investigate potential new therapy for sickle cell disease

La Jolla Institute forms partnership to investigate potential new therapy for sickle cell disease

Affymax completes sale of all auction rate securities held by UBS

Affymax completes sale of all auction rate securities held by UBS

Researchers reveal findings on restricted lineage of iPS cells

Researchers reveal findings on restricted lineage of iPS cells

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Phase 2 CUBICIN study for prosthetic joint infections meets primary endpoint

Phase 2 CUBICIN study for prosthetic joint infections meets primary endpoint

Mother’s obesity surgery may cause vitamin deficiencies in children

Mother’s obesity surgery may cause vitamin deficiencies in children

New research reports evaluating nephrology market in Europe released

New research reports evaluating nephrology market in Europe released

An overview of heart palpitations from Mayo Clinic

An overview of heart palpitations from Mayo Clinic

High blood pressure, diabetes leads to CKD

High blood pressure, diabetes leads to CKD

ACTOS offers safety profile regarding risk of CV events in people with type 2 diabetes: Takeda

ACTOS offers safety profile regarding risk of CV events in people with type 2 diabetes: Takeda

Scientists gather to discuss latest advances in Alzheimer's disease at AAICAD 2010

Scientists gather to discuss latest advances in Alzheimer's disease at AAICAD 2010

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.